ArticleRegional anesthesia and pain medicine2026
Association of patient-reported substance use and postoperative pain.
Article in Regional anesthesia and pain medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundSubstance use among surgical patients is common and correlated with greater postoperative opioid use. However, the association of preoperative substance use on postoperative pain is unknown. In this context, a brief, validated tool such as the Tobacco, Alcohol, Prescription medication, and other Substance use (TAPS) Questionnaire could provide valuable information to assess the risk of poor postoperative pain control.
methodsWe prospectively identified adults aged 18 years and older undergoing common surgical procedures between December 2018 and July 2023 across three institutions. Patients completed the TAPS measure prior to surgery. A positive TAPS screen was defined as tobacco use ≥monthly, heavy alcohol use ≥monthly, any use of recreational drugs, or any use of prescription medication not as prescribed. The primary outcome was 'worst' overall pain (on a scale of 0-10, 0=no pain, 10=worst pain imaginable) at three time points: prior to surgery, 2 weeks postoperatively, and 1 month postoperatively. Mixed linear models were used to determine the association between TAPS Score and pain over time, adjusting for patient factors.
resultsIn this cohort of 4410 individuals, 42.2% reported unhealthy substance use using TAPS in the 12 months prior to surgery. After adjusting for patient factors, participants who screened positively on TAPS reported higher worst overall pain scores than those with negative TAPS screens at baseline (3.51 vs 3.15, p<0.001) and at 1 month postoperatively (2.66 vs 2.41, p=0.036). No significant difference was observed at 2 weeks after surgery.
conclusionsPreoperative substance use is common and is correlated with higher levels of patient-reported pain after surgery, but within minimal clinically important differences. These findings are preliminary and require confirmation. Risky substance use has an important impact on postoperative recovery, and the perioperative window provides an opportunity to assess and intervene in unhealthy substance use.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.